MedPath

Platelet-Rich Plasma (PRP) in Reconstructive Surgery on Children With Retractable Burn Sequelae on Extremities

Not Applicable
Completed
Conditions
Burns
Interventions
Procedure: With PRP
Registration Number
NCT00858442
Lead Sponsor
Corporation for the Aid of Burned Children
Brief Summary

Does the addition of Platelet-Rich Plasma (PRP) to release of burn contractures and skin graft on the limbs of children with retractable burn sequelae reduce the initial time of the compressive treatment and maintain or lower the graft's retraction?

Detailed Description

Hypothesis:

1. The use of PRP will allow to initiate sooner the compressive treatment during the post graft surgery evolution, in fewer days on average than the traditional method (18 ds).

2. The use of PRP will maintain the same initial size of the graft. The study's domain corresponds to burn sequelae on children in treatment with reconstructive surgery due to retractile sequelae located on their upper and lower limbs, with functional compromise during their growth process.

One of the treatments used for this problem is the surgical technique of with release of burn contractures and skin graft.

Split skin grafts are at risk of suboptimal "take" due to bleeding and infection which would, on the one hand, delay the initiation of the rehabilitation with preventive compression to avoid the retraction of the grafted area.

20% of the children that arrive in COANIQUEM (approximately 7,000 annually), require rehabilitation. Of these, 32% have surgery and 9% of those are release of burn contractures and skin graft mainly on extremities.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Patients with burn sequelae on their upper or lower limbs
  • Treated with release of burn contractures and skin graft on their upper or lower limbs
  • Between 5 and 21 years old
  • Following instructions in their homes
  • With informed and written consent
  • Weight 35 Kg or more
  • Blood count
  • Hepatic and coagulation tests
  • Paediatric evaluation prior to surgery
Exclusion Criteria
  • Background of blood alterations
  • Another current pathology

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
With PRPWith PRPEach patient received a single dose of 5cc PRP before the graft.
Primary Outcome Measures
NameTimeMethod
Median Time Between Surgery Date and Start Date Compression.day

Participants were followed from the date of surgery and the date of onset of compression for a minimum of 13.5 days and a maximum of 27 days

Secondary Outcome Measures
NameTimeMethod
Width of the Graftstart and end compression

Central width measurement graft between the start and the end of the compression

Length of the Graftstart and end compression

Central length measurement graft between the start and the end of the compression

Trial Locations

Locations (1)

Coaniquem

🇨🇱

Santiago, Pudahuel, Chile

© Copyright 2025. All Rights Reserved by MedPath